Poly(amido)amine (PAMAM) dendrimer–cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells

Drug transporters of platinum-based anticancer agents and their clinical significance

(2011) Herman Burger et al.   DRUG RESISTANCE UPDATES

Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin

(2011) Gordon J. Kirkpatrick et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Preliminary studies on the selective accumulation of vitamin-targeted polymers within tumors

(2010) Gregory Russell-Jones et al.   JOURNAL OF DRUG TARGETING

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy

(2010) N. Kolishetti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel strategies for reversing platinum resistance

(2009) Mian M.K. Shahzad et al.   DRUG RESISTANCE UPDATES

Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications

(2009) Venkata K Yellepeddi et al.   Expert Opinion on Drug Delivery

Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin

(2009) Teni Boulikas   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands

(2009) Patricia Marqués-Gallego et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Cooperative nanomaterial system to sensitize, target, and treat tumors

(2009) J.-H. Park et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA